Literature DB >> 3821839

Emergence of vancomycin resistance in coagulase-negative staphylococci.

R S Schwalbe, J T Stapleton, P H Gilligan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3821839     DOI： 10.1056/NEJM198704093161507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  138 in total

1.  Evidence for nasal carriage of methicillin-resistant staphylococci colonizing intravascular devices.

Authors:  N B Frebourg; B Cauliez; J F Lemeland
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 2.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy.

Authors:  H Adler; A Widmer; R Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

Review 4.  Antimicrobial resistance: the example of Staphylococcus aureus.

Authors:  Franklin D Lowy
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

5.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

6.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.

Authors:  M Berti; G Candiani; M Borgonovi; P Landini; F Ripamonti; R Scotti; L Cavenaghi; M Denaro; B P Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 8.  Neonatal infections with coagulase negative staphylococci.

Authors:  M R Millar; N Todd; P Mackay
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

9.  In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.

Authors:  Ji-Woong Jeong; Sung-Ji Jung; Hyun-Hee Lee; Yong-Zu Kim; Tae-Kyo Park; Young-Lag Cho; Sang-Eun Chae; Sung-Yoon Baek; Sung-Ho Woo; Hyang-Sook Lee; Jin-Hwan Kwak
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

10.  Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.

Authors:  P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.